T he desmosome is a specialized adhesive junction that interacts with the cytoskeleton and participates in crosstalk with gap and adherens junctions. Mutations in components of the desmosome underlie a variety of cutaneous disorders and arrhythmogenic cardiomyopathy, a disease that bridges the gap between inherited arrhythmia syndromes and heart muscle disorders. 1 The early, "concealed" phase of arrhythmogenic cardiomyopathy is characterized by a propensity to ventricular arrhythmia and sudden cardiac death (SCD) in the setting of well-preserved morphology, histology, and ventricular function. The histological substrate develops with disease progression; myocyte loss is accompanied by inflammation, fibrosis, or adiposis. The disease was first recognized in its classic, right-dominant form as arrhythmogenic right ventricular cardiomyopathy (ARVC) (Figure 1 ). Growing recognition of nonclassic subtypes with early left ventricular involvement supports adoption of the broader term arrhythmogenic cardiomyopathy. 1 Here, we seek to provide a "gene-to-disease" review of the cardiac desmosome and its role as a molecular substrate for cardiac disease.
Structure, Composition, and Function of the Desmosome
The desmosome is a symmetrical protein complex. Each end resides in the cytoplasm of one of a pair of adjacent cells, anchoring intermediate filaments in the cytoskeleton to the cell surface. The middle section spans both cytoplasmic membranes, bridging the intercellular space. The end result is a 3D network that lends structural support to tissues. 2 Besides these stabilizing and adhesive functions, desmosomes have important roles in tissue morphogenesis during embryonic development and wound healing. Desmosomal components can translocate to other subcellular compartments, participate in signaling pathways, and thereby influence transcriptional regulation of genes involved in proliferation and differentiation. [3] [4] [5] Inherited abnormalities of the desmosome therefore have diverse consequences. In the past 2 decades, detailed phenotyping of various cardiac and cutaneous disorders has underscored the versatility of desmosomes. Parallel molecular studies of desmosome structure and function have shed light on the cellular and molecular mechanisms underlying a variety of disease states.
Desmosomes: Distribution and Structure
Desmosomes were initially described as "discontinuous, button-like" structures of epithelial tissue. 6 They are particularly abundant in the follicular/interfollicular epidermis but are also found in myocardium, dendritic reticulum cells in lymph node follicles, and meningeal tissue. Desmosome distribution is consistent with a primary role in strengthening tissues exposed to mechanical stress and is remarkably similar between species. Desmosomal structure is also highly conserved throughout vertebrate evolution. Electron microscopy depicts a distinctive lamellar appearance ( Figure 2 ). 3, 4 The highly insoluble nature of the constituent glycoproteins has posed a significant challenge to elucidation of desmosomal structure; the present understanding is based largely on a combination of in vivo protein interaction and reconstitution studies. The products of 3 gene superfamilies assemble to form desmosomes: the desmosomal cadherins, the armadillo family of nuclear and junctional proteins, and the plakins (Table) . 
Desmosomal Cadherins
The cadherins are a superfamily of calcium-dependent adhesion molecules with auxiliary functions in embryogenesis, stem cell fate and maintenance, cell polarity, and signal transduction. Structurally, they are characterized by extracellular domains containing various numbers of Ϸ110-aa motifs, which function in adhesion and calcium binding. 5 Phylogenetic analysis suggests that classic (type 1), atypical (type 2), and desmosomal cadherins originated from a common ancestor. 7 During evolutionary divergence, variations arose in the cytoplasmic domains to enable interaction with different protein ligands. The desmosomal cadherins include 4 isoforms of desmoglein (DSG1 to -4) and 3 of desmocollin (DSC1 to -3), all encoded by separate genes that are clustered together on opposite sides of a central region on chromosome 18q12.1. Shared control by a long-range master regulatory region has been postulated. The 3 DSC genes each have long ("a") and short ("b") protein products, generated by alternative splicing (Figures 3 and 4) . 5, 8, 9 Expression of the desmosomal cadherins appears tissue-specific. DSC-2 and DSG-2 are expressed in all desmosome-containing tissues, including colon and cardiac muscle, whereas distribution of the other isoforms is confined primarily to stratified epithelial tissue. 10 
Armadillo Family
Proteins belonging to the armadillo family have a central domain containing a variable number of imperfect 42-aa repeats. Desmosomal armadillo family members include junctional plakoglobin (JUP) and the 4 plakophilins (PKP1 to -4), which reside within the desmosomal plaque (Figures 3 and 4) . 8, 10, 11 In terms of tissue distribution, PKP2 and PKP3 are found in almost all desmosome-bearing cell types, with the exception of the differentiated cells of the stratified epithelium (which lack PKP2) and hepatocytes and cardiac myocytes (both of which lack PKP3). In contrast, PKP1 expression is restricted to the stratified and complex epithelia. 12 Distribution of both JUP and PKP4 is more widespread owing to their Figure 2 . Electron micrograph of desmosomal structure. The intercellular space is between 20 to 35 nm wide with a prominent electron-dense midline. Running parallel to it, on either side, are at least 4 distinct bands: (1) a lucent zone; (2) a dense line just outside the cell surface; (3) the cytoplasmic membrane; and (4) an opaque region inside the cytoplasm, which can be further subdivided into the outer dense plaque (ODP) and inner dense plaque (IDP) based on increasing distance from the cell surface. Reproduced from Al-Amoudi and Frangakis 4 with permission from the Biochemical Society. DM indicates dense midline; EC, extracellular core; PM, plasma membranes. 
Specific Observations of Desmosomal Function
Desmosomes can adopt 2 alternative states that differ in adhesive affinity, the stronger of which is termed "hyperadhesive." Experimentally, it is characterized by calcium independence. Chelating agents deplete extracellular calcium and would generally be expected to compromise junctions, leading to rapid internalization. The hyperadhesive desmosome is, however, resistant to such disruption, a possible corollary of calcium ions being trapped within the structure. 10 Hyperadhesion appears to be the normal state of tissue desmosomes. The dense midline of the desmosomal junction apparent on electron microscopy is thought to contain the extracellular domains of the desmosomal cadherins in a highly organized arrangement requisite for hyperadhesiveness. These high-affinity bonds confer structural support at the expense of cell motility. Desmosomes retain the flexibility to shift to a lower-affinity state during wound healing and embryogenesis. Keratinocytes, for example, form a single layer during epidermal injury repair to facilitate migration under the clot and closure of the wound. Downregulation of adhesion is requisite to release keratinocytes from multilayered epidermis; thus, desmosomes in wound-edge epidermis are calcium-dependent and lack the characteristic dense midline. 10 Emerging evidence suggests that intracellular signaling may facilitate the switch from the hyperadhesiveness of desmosomes in mature tissues to a more dynamic state. The structure of the outer and inner dense plaques is still being defined but purportedly shares the high level of organization observed in the intercellular space. Plaque proteins may undergo enzymatic phosphorylation, in particular, by protein kinase C␣ from the serine/threonine kinase family. Large anionic phosphate groups disturb the molecular arrangement within the plaque, with transmission of the resulting disorder to extracellular domains. The desmosomal cadherins, in turn, bind with lower affinity and become calcium-dependent. Interaction of protein kinase C␣ with PKP2 is also necessary for phosphorylation and recruitment of desmoplakin to nascent desmosomes. The role of these mechanisms in myocardial injury repair remains an active area of research. 10, 14 The paragraphs above provide a general overview of the molecular characteristics of desmosomes and desmosomal molecules. Although abundant additional information exists, the present review is limited by scope and space. In-depth reviews on transcriptional and posttranslational regulation of desmosomal proteins, desmosomal assembly, desmosomal protein interactions and related topics can be found in the literature (eg, see elsewhere 5,10 -18 ). Worth noting is the extensive work that has been conducted on (1) the structural roles of cadherins as single-pass transmembrane proteins that are essential for strong Ca 2ϩ -dependent cell-cell adhesions; (2) the role of armadillo proteins as mediators of cytoplasmic interactions for strong adhesion and cytoskeletal attachment; (3) the function of PKP2 as a scaffold for protein kinase C␣, regulating the association of desmoplakin with intermediate filaments; and (4) the role of desmoplakin in the crosstalk between adherens junctions and desmosomes and RhoAmediated actin assembly and organization (see other reviews 10 -18 and references within). In the following sections, we focus our attention on desmosome-related diseases and on the possible cellular/molecular mechanisms underlying ARVC.
Desmosomes and Human Disease: Desmosomal Genotypes and Clinical Phenotypes
Desmosomes first came to the attention of the cardiovascular community interested in inherited arrhythmogenic diseases with the identification of a homozygous mutation in one of its components (JUP) as the cause of Naxos disease: a triad of palmoplantar keratoderma (PPK), woolly hair, and ARVC. The cutaneous features, which are expressed from infancy, facilitated recognition of homozygotes for initial mapping of the disease locus to 17q21. There were various candidate genes in this region, but plakoglobin knockout mice were known to exhibit embryonic skin and heart defects reminiscent of the Naxos phenotype, making it a prime contender. Accordingly, in 2000, Naxos syndrome became the first human disease causally linked to a defect in plakoglobin, whereas plakoglobin provided the first glimpse into the genetic basis of ARVC. 19 Because numerous sequence variants were identified in related genes, desmosomal dysfunction was proposed as the final common pathway of disease expression in ARVC. Within a quarter of a century, the prevailing concept of ARVC had evolved from a developmental anomaly (the source of its original designation, right ventricular dysplasia) to a genetic defect of cell adhesion. Novel as the desmosomal junction might have been to cardiologists interested in inherited arrhythmia disorders, however, it had been well known in the field of dermatology for at least the preceding decade (Table) .
Desmosomal Cadherins

Cutaneous Phenotypes Pemphigus
Pemphigus is a blistering skin disease associated with acantholysis (loss of intercellular adhesion between keratinocytes). Of its various forms, paraneoplastic pemphigus is the least common and typically occurs in the setting of lymphoproliferative disease. The 2 more prevalent forms are of interest as autoimmune diseases of the desmosome. Pemphigus foliaceus is present in 10% to 20% of cases and affects the epidermis, sparing the mucous membranes. Pemphigus vulgaris, which accounts for the majority of cases, has 2 subtypes: mucosal dominant and mucocutaneous. Pemphigus foliaceus is associated with autoantibodies against DSG1, which is distributed primarily in the upper layers of the cutaneous epidermis, consistent with mucosal sparing. The target autoantigen in pemphigus vulgaris is DSG3, which is prominently expressed in the tongue, tonsils, and bronchoepithelial cells, accounting for preferential involvement of the mucous membranes. Up to 50% of individuals with pemphigus vulgaris also develop autoantibodies against DSG1, accounting for subsequent evolution of the mucocutaneous subtype. Although pemphigus is an autoimmune rather than a genetic disorder, it underscores the importance of the desmosomal cadherins in promoting normal cell adhesion. Pemphigus also serves as an example of how dysfunction of different protein isoforms can lead to variations in phenotype. 20, 21 Palmoplantar Keratoderma The PPKs are a heterogeneous group of disorders of keratinization, characterized by epidermal thickening of the palms of the hands and the soles of the feet. Involvement may be diffuse (affecting most of the palmar and plantar surfaces) or focal (typically localized to pressure points). Both hereditary and acquired forms are recognized. Striate PPK (SPPK) is an uncommon subtype inherited as an autosomal dominant trait. A number of heterozygous mutations in DSG1, predicted to result in haploinsufficiency, have been identified in SPPK families. However, if autoantibodies against DSG1 cause superficial blistering on the trunk and scalp, why does haploinsufficiency result in SPPK? 6, 21 Acantholysis in pemphigus appears to result from cooperative action of antibodies on different keratinocyte selfantigens. At least 2 mechanisms have been proposed for the pathogenesis of striate PPK. Normal skin responds to repeated trauma with thickening of the stratum corneum, outwardly visible as callous formation. Haploinsufficiency of DSG1 may impair innate resistance so that the protective thickening response occurs at lower levels of mechanical stress. Alternatively, aberrant ratios of desmoglein isoform expression are purported to induce changes to tissue morphology. Other desmosomal components have also been implicated in PPK. 21 Inherited Hypotrichosis DSG4 is the principal desmosomal cadherin of the hair follicle, where it mediates keratinocyte cell adhesion and coordinates the transition from proliferation to differentiation. A mutation in DSG4 (EX5_8del) has been reported in 3 families with inherited localized hypotrichosis: a rare, autosomal recessive form of hair loss affecting the scalp, chest, arms, and legs. 21 Arrhythmogenic Cardiomyopathy DSG2 was the fourth desmosomal protein to be implicated in ARVC. Pilichou et al identified 9 heterozygous mutations in DSG2 (5 missense, 2 insertion-deletions, 1 nonsense, and 1 splice site) in 8 of 54 probands (10%) screened on a candidate-gene basis. One patient carried both a missense (DSG2-E331K) and a splice site defect (DSG2-1881 to 2A3 G) in trans configuration. Endomyocardial biopsies showed characteristic myocyte loss with fibrofatty replacement; on electron microscopy, the intercalated discs appeared pale, with reduced desmosome number, and widening of the intercellular gap. The clinical phenotype included left ventricular involvement in Ϸ50% of cases. No overt skin/hair abnormalities were observed. 22 Prominent left ventricular involvement was present in 25% of the DSG2 cases reported by Syrris et al, who also noted relatively high penetrance within families. 23 Of the 4 cases with DSG2 mutations described by Awad et al, one was a compound-heterozygote who had developed a disseminated cutaneous exanthema with extensive mucosal involvement after receiving penicillin as a child. 24 A possible homozygous mutation in DSG2 (S1059T) has been also identified in a 36-year-old proband of Pakistani origin; the phenotype was ARVC without overt cutaneous abnormalities, but relatives were not available for evaluation and a racial polymorphism has not been excluded. 25 Recently, Milting and Klauke 26 and Posch et al 27 have cast doubt on the pathogenicity of certain variants in DSG2. The E713K, V56M, V158G, and V920G alleles have been identified in healthy control subjects at frequencies of 13.9, 0.5, 2.2, and 0.8% respectively. Posch et al have also reported that 2.4% of cases with dilated cardiomyopathy were carriers of DSG2-V56M: a significant overrepresentation compared with controls, consistent with a role as a susceptibility allele. Immunostaining and electron microscopy of explanted left ventricular myocardium from these patients revealed irregularly shaped intercalated disks and, in a homozygous carrier, shortening of the desmosome. 28 Although the disputed DSG2 alleles may be insufficient per se to cause ARVC, they may confer increased predisposition to it, accounting for the previously observed cosegregation with phenotype in affected families.
Delmar and McKenna Phenotypic Manifestations of Desmosomal Disease
Of the 3 desmocollins, only 1 (DSC2) has been implicated in human disease to date. In 2006, shortly after the first report of DSG2 defects in arrhythmogenic cardiomyopathy, Syrris et al identified 2 heterozygous mutations in DSC2, a deletion (1430delC) and an insertion (2687_2688insGA). Both result in frameshift and premature truncation of the DSC2 protein. 29 The phenotype in the families was ARVC with prominent left ventricular involvement, which, in the classic natural history of the disease, is generally a late stage complication that arises after the onset of global right ventricular dysfunction. In contrast, the extent of left ventricular disease in some of the individuals with DSC2 mutations was suggestive of early involvement of both ventricles. 25, 30 There were no hair or skin abnormalities. It was suggested that DSC1 and DSC3 might compensate for the defective DSC2 isoform in epithelial cells, but not in cardiac myocytes, where only DSC2 is expressed. More recently, Simpson et al have reported a homozygous single-base deletion in exon 12 (1841delG) of DSC2 in a consanguineous family. The mutation is predicted to lead to frameshift and premature truncation of the protein product. Both the proband and his sister had ARVC with left ventricular involvement but were further distinguished by the presence of woolly hair and mild PPK. 31 The gene dose effect of a homozygous mutation may exceed the ability of other DSC isoforms to compensate.
In summary, mutations in desmosomal cadherins DSG2 and DSC2 account for Ϸ10% of cases of arrhythmogenic cardiomyopathy in published series from the United Kingdom and The Netherlands. 32, 33 Homozygotic, compound-and double-heterozygotic states have been identified, suggesting that a proportion of defects in these genes may be of low pathogenicity and less likely, in isolation, to cause penetrant disease. The phenotype includes characteristic histological and clinical features of ARVC, with prominent left ventricular involvement in many cases. PPK and woolly hair have been observed in a homozygote with a DSC2 mutation. 24, 25, 31, 33 Desmosomal Plaque Proteins (Armadillo Family)
Cutaneous Disease
Expression of PKP1 is concentrated in the suprabasal layers of stratified and complex epithelia but also identifiable in the basal and granular cell layers, although absent from the stratum corneum. Compound heterozygous chain-termination mutations in the PKP1 gene cause the rare autosomal recessive disorder, ectodermal dysplasia (skin fragility syndrome). Clinical consequences include trauma-induced erosions, blistering, hyperkeratosis of palmoplantar skin, sparse hair, nail dystrophy, and reduced sweating. Such cases of spontaneous ablation of PKP1 underscore its importance in epidermal intercellular adhesion and morphogenesis. 6, 21 Arrhythmogenic Cardiomyopathy Naxos disease is a cardiocutaneous syndrome caused by a homozygous 2157del2 mutation in JUP, which results in frameshift and premature termination of translation. There is alteration of the last 5 amino acid residues in the 13th armadillo repeat of the protein product, with truncation of the C-terminal domain by 56 residues. McKoy et al confirmed the presence of the mutant protein in an endomyocardial biopsy sample from an affected patient. 19 Homozygotes for JUP-2157del2 demonstrate woolly hair and diffuse PPK from infancy. Cardiac abnormalities may arise from early childhood but, in general, affected individuals develop symptoms (syncope and sustained palpitation) and fulfil diagnostic criteria from adolescence onwards. The disease pattern is classic; ECG abnormalities include QRS prolongation, epsilon waves, and inverted T waves in the right precordial leads (V1 to -3); Ͼ90% of Naxos patients have arrhythmia of right ventricular origin and structural/ functional abnormalities of the right ventricle. Left ventricular involvement occurs with disease progression, manifesting as extension of T-wave inversion to the lateral leads (V4 to -6), with left-sided structural and functional abnormalities on echocardiography. Heart failure develops in Ϸ25% of patients. The annual incidence of sudden cardiac death is Ϸ3%, slightly higher than that reported in non-referral center populations with the more common, dominant form of ARVC. 19, 34 A minority of heterozygotic carriers of JUP-2157del2 show clinical features compatible with mild disease expression. Protonotarios et al reported that 8 of 40 heterozygotes had minor cardiac abnormalities, including inverted T waves in V1 and V2 (nϭ4), mild right ventricular dilation (nϭ3), and T-wave inversion in V1 to -3 with mild right ventricular outflow tract dilation. Five carriers also had woolly hair. None, however, fulfilled diagnostic criteria for ARVC or developed ventricular arrhythmia, and PPK was not observed. 34 The clinical abnormalities of ARVC are nonspecific in isolation and imaging abnormalities, in particular, may be prone to overinterpretation. Nevertheless, the possibility arises that Naxos syndrome is not a recessive disease so much as an extreme phenotype arising from a gene-dose effect.
For some years, it was conjectured that JUP variants were of insufficient pathogenicity to cause dominant ARVC. In 2007, however, a German family with ARVC was found to have a heterozygotic JUP mutation (118_119insGCA), predicted to result in insertion of an additional serine residue at amino acid position 39 within the N-terminal domain of the protein product (JUP-S39_K40insS). The phenotype was classic right ventricular disease without hair or skin abnormalities. 35 Ly et al subsequently reported a heterozygous missense mutation (V159L) in the first armadillo repeat domain of plakoglobin, known to mediate interactions with desmosomal cadherins. The affected patient had biventricular arrhythmogenic cardiomyopathy without obvious cutaneous abnormalities. The diagnosis was made after an incidental finding of a left ventricular aneurysm on a CT scan for abdominal pain. ECG showed isolated inferolateral T-wave inversion. The features of early left ventricular involvement in this case contrast with the classic pattern exhibited by other JUP mutations. 36 The other armadillo protein to have been implicated in ARVC is PKP2, which probably accounts for the highest proportion of cases. The prevalence of heterozygous variants in PKP2 was 27% and 43% among ARVC patients in the German and US studies, respectively, and 70% among familial cases in The Netherlands, which is strikingly higher than the 9% to 14% reported in the London and Padua cohorts. 32, 37 Common haplotypes consistent with founder effects were identified in the Dutch population but not the others. 37 At least part of the residual difference in the frequency of PKP2 disease may be attributable to recruitment strategy. The phenotype associated with PKP2 mutations appears to be that of classic ARVC. Left ventricular involvement is recognized but much less prominent than that observed in conjunction with other gene mutations. The ECG and imaging findings emphasize the right-sided predilection for which the disease was originally named. Cohorts ascertained from patients with arrhythmia of right ventricular origin may therefore include a relatively high proportion of PKP2 mutants. In contrast, the UK and Padua experience reflects the focus on familial evaluation of (frequently deceased) index cases, resulting in a different case mix that downplays the impact of PKP2 disease. 32 Dalal et al reported on the penetrance of PKP2 mutations, highlighting age-related expression and wide intrafamilial variation. 38 True nonpenetrance was inferred in at least 2 individuals who remained free from disease over the age of 70. Two recent studies have provided additional insight into the reduced penetrance of PKP2 mutations. Christensen et al found 3 previously reported missense variants, originally presumed causal, in 0.5% to 1.4% of healthy control subjects. 39 Although a causal link to ARVC is unlikely, all 3 variants were selectively enriched among cases compared with controls, suggesting a possible contribution to disease expression. Shortly thereafter, Xu et al highlighted that PKP2 variants, including nonsense and frameshift changes, are frequently insufficient, in isolation, for penetrant disease. Among a series of 38 index cases with ARVC harboring PKP2 defects, 9 were compound heterozygotes. A further 16 (42%) were double heterozygotes, with additional rare variants in other desmosomal genes (among which was PKP4, framing it as a candidate gene for ARVC). 40 The genetics of ARVC may therefore be more complex than hitherto appreciated, with frequent requirement for more than one "hit" for clinical disease expression.
To date, skin or hair abnormalities have not been observed in conjunction with PKP2 mutations, not even in the sole reported case of a homozygote with a cryptic splice mutation (PKP2-2484CϾT). Equally, PKP1 defects lead to skin disease without cardiac involvement. Syrris et al offered a clue to the basis for these disparate phenotypes. In cardiac myocytes, the PKP2 isoform is found in the desmosomal plaque, whereas PKP1 is confined to the cell nucleus. The situation is reversed in the epidermis, where PKP1 localizes to the desmosomal plaque, but PKP2 is found in the nucleus. 41 Although various explanations might be put forth, dysfunction of the desmosome itself appears pivotal.
Insights From JUP Mutations
A case report of a child with Naxos disease has effected a watershed in our understanding of the pathogenesis of ARVC. The girl was a confirmed homozygote for the Naxos mutation and had typical cutaneous features. Cardiac evaluation at the age of 5 revealed right ventricular ectopy (Ͼ14 000 in 24 hours) and abnormal right precordial epsilon waves on the 12-lead ECG. She was subsequently diagnosed with myelodysplasia and, despite chemotherapy and a successful bone marrow transplant, developed acute nonlymphocytic leukemia, leading to her death at age 7 years. Rigorous postmortem examination of her heart failed to identify any fibrofatty replacement of the myocardium, leukemic infiltrates, or degenerative features of cardiac myocytes consistent with chemotherapy-related injury. 42 The cellular-molecular basis for her ECG and arrhythmia remained unresolved until a combination of electron microscopy, immunohistochemistry, and immunofluorescence studies were performed. Key findings included a reduction in the number and size of gap junctions and diminished expression of connexin (Cx)43 (the major gap junction protein) at intercalated discs. 42 These features have also been observed in other hearts from Naxos patients, in the single available heart from a Carvajal patient (see below), and in PKP2 mutants. 43, 44 Although gap junction remodeling occurs in many disease states, including ischemic heart disease and heart failure, it is generally in the setting of histological substrate. In arrhythmogenic cardiomyopathy, by contrast, it arises in histologically unaffected regions of the myocardium. The case of the Naxos child, in particular, was distinguished by the presence of gap junction remodeling in a structurally and histologically normal heart.
Plakin Family: Desmoplakin
Cutaneous Disease Acquired and hereditary cutaneous phenotypes, similar to those recognized for PKP1, may also be caused by autoimmune and/or genetic desmoplakin disease. Autoantibodies directed against desmoplakin have been identified in paraneoplastic pemphigus, pemphigus foliaceus, pemphigus vulgaris, and erythema multiforme, although their role in pathogenesis awaits further elucidation. Their occurrence in pemphigus vulgaris, for example, has been attributed to an epitope-spreading phenomenon. Heterozygous mutations resulting in haploinsufficiency of DSP (eg, Q331X and 939ϩ1 GϾA) have been identified in autosomal dominant striate PPK. Compound heterozygosity for nonsense/missense mutations in DSP is associated with recessive PPK and woolly hair/alopecia. 6, 21 Cardiocutaneous Syndromes In 1996, Rao et al reported a familial occurrence of PPK, woolly hair, and dilated cardiomyopathy in India. 45 Dr Luis Carvajal-Huerta subsequently observed a similar phenotype in Ecuadorian families. Norgett et al identified the causative mutation as a homozygous deletion in DSP (7901delG), which results in a premature stop codon and a truncated protein product lacking the C domain of the tail region. 46 The cardiac phenotype includes inverted T waves in V1 to -3, extending in some cases to V5, and frequent and complex ventricular arrhythmia, both consistent with ARVC despite being originally described as dilated cardiomyopathy. In the single postmortem heart so far examined, the left ventricle was grossly dilated with aneurysms in the posterior and anteroseptal walls. The right ventricle showed more modest dilation, with aneurysms in the triangle of dysplasia. Extensive myocyte loss and replacement fibrosis, with a predilec-
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tion for the subepicardium, was apparent on histology. 43 Taken together, the entity might be best described as a left-dominant or biventricular subtype of arrhythmogenic cardiomyopathy. 2, 30 Alcalai et al have reported a case with recessive ARVC, woolly hair, and a blistering, pemphigus-like skin disorder in a consanguineous Arab family. The causal mutation was a homozygous 7402GϾC substitution in exon 24 of DSP, resulting in G2375R missense change in the protein product. Eight family members had died suddenly before the age of 35, all of whom had woolly hair, extremely dry skin from infancy, and vesicular lesions at the extremities, knees, palms, and soles from childhood. The living affected homozygote had ventricular tachycardia of midseptal origin, right precordial T-wave inversion, and a mildly dilated right ventricle on echocardiography. Left ventricular involvement was apparently not a prominent finding. 47 In 2006, Uzumcu et al described a child from a consanguineous family with a homozygous nonsense mutation (R1267X) in exon 23 of DSP. This defect results in truncation of the larger DSP-I isoform only (with loss of most of the rod domain and C-terminal area). The phenotype comprised woolly hair, epidermolytic PPK, and a biventricular cardiomyopathy with onset by the age of 3 years. Frequent and complex ventricular arrhythmia and progressive left ventricular systolic dysfunction were observed, with death from heart failure in childhood. In the heterozygous mother, the amount of DSP-I transcript was reduced by Ϸ50%, suggesting nonsense-mediated mRNA decay. DSP-I transcript may have been completely absent in the homozygotic child. 48 DSP-I is known to be the dominant isoform in cardiac tissue and is ubiquitously expressed in heart and aorta. Nevertheless, Uzumcu et al also amplified DSP-II on a cardiovascular cDNA panel, revealing transcript in the left atrium and ventricle, interventricular septum, and apex, albeit at significantly lower levels than that of DSPI. Right-sided expression was minimal. DSP-II transcript was also detected in fetal heart tissue. Cardiac expression of DSP-II in this case may have enabled survival through the fetal period to early childhood; in contrast, desmoplakin-null mice die in embryo. 48 Jonkman et al expanded the spectrum of DSP-related cardiocutaneous syndromes further with a description of lethal acantholytic epidermolysis bullosa in a child with compound heterozygosity for DSP-R1934X and DSP-6370delTT, both of which are located in exon 24 and result in chain termination. Immunoblot staining of keratinocytes revealed 2 truncated DSP-I polypeptides, lacking the tail region that binds to intermediate filaments. The phenotype included severe fragility of skin and mucous membranes, universal alopecia, loss of teeth and nails, and was lethal in the neonatal period. 49 Bolling et al reported a similar phenotype in 2 infants born to the same consanguineous parents, with a homozygous deletion (C2874del5) resulting in truncation of the rod domain and C terminus of DSP (p.Lys959MetfsX5). In these cases, ventricular dilation and dysfunction were also evident from antenatal scans. 50 
Arrhythmogenic Cardiomyopathy
Desmoplakin became the first gene to be implicated in autosomal dominant ARVC; in 2002, Rampazzo et al isolated a missense mutation (S299R) in exon 7 of DSP in an Italian ARVC family. The defect suppresses a putative phosphorylation site in the N-terminal domain of DSP, which binds to plakoglobin. The phenotype was classic ARVC, with right precordial T-wave inversion and arrhythmia of right ventricular origin in affected family members and several instances of ventricular fibrillation/sudden cardiac death. Echocardiography showed severe right ventricular dilation and systolic dysfunction. Wall motion abnormalities were observed in the left ventricle in 3 cases. Nevertheless, the right to left ventricular volume ratio exceeded 1.7, and the right ventricular ejection fraction was markedly more reduced than the left. 51 Three years later, Norman et al described a family with a heterozygous mutation in DSP (2034insA), resulting in frameshift, premature chain termination, and truncation of the rod and C terminus of the protein product, which was predicted to alter desmin desmoplakin binding. The distinctive phenotype included inferolateral T-wave inversion, arrhythmia of left ventricular origin and minor/absent left/right ventricular abnormalities on conventional echo/cardiac magnetic resonance imaging, but with prominent late gadolinium enhancement of the left ventricular myocardium. The profile was consistent with a left ventricular arrhythmogenic cardiomyopathy. 52 Bauce et al 53 presented a detailed characterization and follow-up of 4 families with DSP mutations: the original reported by Rampazzo et al, 51 R1775I, R1255K, and the splicing mutation c.423 to 1GϾA. Noteworthy aspects of the phenotype included presentation with chest pain and myocardial enzyme increase in 2 cases. In a 15-year-old carrier who suffered sudden death, postmortem examination revealed acute-subacute myocyte necrosis, inflammatory infiltrate, and loose fibrous and granulation tissue. 53 Myocarditis has long been a recognized histological feature of arrhythmogenic cardiomyopathy, occurring in up to 67% of cases; in this adolescent, however, it was the most prominent finding. A pathologist unaware of the gene carrier status might have ascribed the death to myocarditis. Approached from the opposite angle, the possibility arises that a proportion of sudden deaths attributed to myocarditis may, in fact, represent early arrhythmogenic cardiomyopathy before the development of myocytolysis and fibrofatty replacement.
A relatively high prevalence of left ventricular involvement was emphasized in the Italian DSP families. Reexamination of the data allows differentiation of late-stage left ventricular involvement (a feature of classic disease expression) from the left-dominant subtype of arrhythmogenic cardiomyopathy. In 3 of the families, reduced left ventricular ejection fraction occurred solely in individuals who also had severe right ventricular dilation and dysfunction. In contrast, 2 subjects with the splicing mutation (predicted to produce a premature stop codon and a truncated protein product) had left ventricular systolic dysfunction in the context of preserved or minimally impaired right ventricular function. One of these patients also had isolated lateral T-wave inversion, characteristic of left-dominant disease. 1, 2, 54 Compilation of genotype-phenotype associations suggests that left ventricular involvement is prominent in the setting of DSP mutations. Nevertheless, as noted above, notable left ventricular disease may also occur in conjunction with defects in the desmosomal cadherins DSG2 and DSC2. In a genetically heterogeneous cohort, chain-termination mutations in any desmosomal gene were associated with an increased severity of left ventricular involvement, manifested as significantly lower left ventricular ejection fraction, more extensive left ventricular late enhancement, and higher prevalence of lateral T-wave inversion and arrhythmia of RBBB morphology (ie, left ventricular origin). 25 
Unresolved Questions
Differential tissue distribution accounts for PKP1-related skin disease and PKP2-related ARVC. With desmoplakin, the propensity toward cutaneous versus cardiac disease is less easy to explain. The reported phenotypes may, however, be less clear cut than currently appreciated. For example, no cardiac involvement was recognized in patients with PPK secondary to haploinsufficiency of DSP, or woolly hair/skin fragility from compound heterozygous mutations but comprehensive cardiovascular evaluation is not described in the studies. Arrhythmogenic cardiomyopathy is frequently asymptomatic, clinical abnormalities are subtle or absent in early disease, and age-related expression is common. The possibility that some patients with exclusively cutaneous phenotypes may have mild cardiac disease, or develop ARVC in later life, cannot be excluded. Strengthening this premise is the recent identification of the DSP-939ϩ1 GϾA mutation in a middle-aged patient with left-dominant arrhythmogenic cardiomyopathy. 30 Similarly, although cutaneous involvement was not overt in the cardiac patients, skin biopsies to detect occult disease were not routinely performed. Anecdotally, a number of patients with DSP mutations have drawn attention to their naturally curly hair and persistently dry skin, implying the presence of subclinical cutaneous manifestations.
Possible Cellular/Molecular Mechanisms Underlying ARVC: The Intercalated Disc As a Functional Unit
The identification of causal mutations in JUP, DSP, PKP2, DSG2, and DSC2 fomented the view that desmosomal dysfunction might be the final common pathway in the pathogenesis of ARVC. The primary model focused on the role of the desmosome in imparting mechanical strength to tissue, both via intercellular adhesion and through transmission of force between the junctional complex and the intermediate filaments in the cytoskeleton. A desmosomal gene mutation may compromise either cell-cell adhesion, or intermediate filament function, or both, depending on its precise location and impact on protein structure and function. The right ventricle may be particularly vulnerable to impaired cell adhesion, owing to its thin walls and high distensibility, an adaptation to wide physiological variations in preload. In contrast, defects causing truncation of the C terminus of desmosomal proteins may result in dominant and/or severe left ventricular involvement through disruption of intermediate filament binding, a mechanism that might take on particular importance in desmoplakin mutants owing to its direct interaction with desmin. Because disease subtypes (rightdominant, biventricular, and left-dominant) may coexist within families, however, the primary mutation cannot be solely responsible for the differences, and a modifier effect must be invoked. 20 Significant myocyte loss in either ventricle may be associated with an inflammatory response. Because the regenerative capacity of the myocardium is limited, repair by fibrofatty replacement takes place. Both inflammation and fibrofatty islands are potential sources of ventricular arrhythmia. Several laboratories have also investigated how disruption of desmosomal integrity per se can alter the electric stability of the heart, with a focus on the interactions of complexes that reside at the cardiac intercalated disc.
The Cardiac Intercalated Disc As a Morphological Entity
The first description of the intercalated disc was in 1866, by Ebhert, who considered this structure to be a homogeneous "cementing material" at cell boundaries between cardiac myocytes. This concept of the myocardium as a continuous syncytium with no cell boundaries was challenged by the electron microscopic images of Sjostrand and Anderson in 1954 and 1958, which demonstrated that heart muscle cells are individually separated from one another and that the intercalated disc represents a "special differentiation of the sarcoplasm in connection with transversally oriented cell boundaries." This work led to the description of the intercalated disc as composed of 3 separate structures, discernible by electron microscopy: desmosomes, adherens junctions, and gap junctions.
Gap Junctions
In 1958, Sjöstrand et al described an area of specialization in the cardiac intercalated disc composed of "three dark lines with two intervening less dense lines." This structure, which was similar to the one previously identified in the giant axon of the crayfish, was named the "longitudinal connection." Years later, Revel coined the term "gap junctions" thus emphasizing the 2 key features: a gap between the cells and yet a junction between them (see elsewhere 55 for review). Gap junctions are involved in a number of biological functions. Most relevant to this review, gap junctions form intercellular channels that provide a low-resistive pathway for direct cell-to-cell passage of electric current between cardiac myocytes. [55] [56] [57] [58] Each gap junction channel is composed of 2 hexameric structures called connexons that dock across the extracellular space and form a permeable pore isolated from the extracellular space. Each connexon results from oligomerization of an integral membrane protein called connexin. The most abundant connexin isotype in the heart and other tissues is the 43-kDa protein Cx43. The importance of Cx43 in the propagation of the cardiac action potential is well established. If Cx43 channels are not present, normal propagation is disrupted and lethal arrhythmias ensue. 56, 57 Thus, understanding the fate of connexins in cardiac disease bears relevance to the understanding of the arrhythmogenic substrate.
Adherens Junctions
Adherens junctions are specialized structures essential for the mechanical coupling between neighboring cells. Cell-cell mechanical anchoring occurs at 2 crucial points: the extracellular space, where cadherins tightly bind to each other; and
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the intracellular space, where the cytoplasmic end of cadherin is indirectly attached to the actin cytoskeleton. The association between cadherin and the cytoskeleton involves at least 2 molecular "hinges": cadherin binds to ␤-catenin and plakoglobin, and both molecules in turn bind to ␣-catenin (among other possibilities), the latter being in direct contact with actin. 14 This is only a simplified description, because other interactions are likely to occur. 59 This string of intermolecular interactions provides mechanical continuity between cells.
The Area Composita
Although a distinction continues to be made between "desmosomes" and "adherens junctions," a recent study of the ultrastructure of the adult mammalian heart supports the notion that these 2 domains are not morphologically distinct; rather, the cardiac intercalated disc shows (in addition to gap junctions) 1 prominent electron-dense structure, dubbed the "area composita," with mixed characteristics of the 2 types of mechanical junctions. Immunogold electron microscopy staining further showed that this area composita harbors proteins immunoreactive to both PKP2 and desmoplakin. 60 -62 This is consistent with evidence (in non cardiac cells) demonstrating the presence of PKP2 at junctions formed by "classic" cadherins 63 and indicates that the interaction of armadillo and cadherin proteins is more promiscuous than initially thought.
The Intercalated Disc As a Functional Unit
The first description of the intercalated disc preceded the availability of immunochemical techniques to identify the subcellular localization of individual proteins. Molecular complexes not compact enough to produce a discernible image at the electron microscope level escaped early observations. This view has progressively changed, based on data demonstrating that the intercalated disc hosts a number of molecules not traditionally considered "junctional," that is, not involved in providing a physical continuum between neighboring cells. Moreover, these molecules also form complexes of their own, in a way that their function is defined, in large part, by their microdomain. Of particular relevance to cardiac electrophysiology, and the topic of this review, is the presence of the voltage gated sodium channel complex that localizes preferentially at the intercalated disc. 64 -66 Among the molecules relevant to sodium channel function are the sodium channel ␣ subunit (mostly Nav1.5 in heart), its ␤ subunits (␤1 to ␤4), and the cytoskeletal adaptor protein ankyrin-G. Worth noting, the sodium channel ␤ subunits are well identified as adhesion molecules in other cell systems. 67, 68 Whether they participate in cell-cell mechanical coupling in the heart is a subject of future investigation.
Crosstalk at the Intercalated Disc
The original description of the intercalated disc identified 3 structures (desmosomes, adherens junctions, and gap junctions); recognition of the "area composita" and the determination of interactions between intercellular adhesion molecules and gap junctions suggests that these may be 3 elements of a single functional unit. 69 In 1990, Musil et al showed that communication-deficient cells could convert to a communication-competent phenotype by transfection with a cDNA encoding E-cadherin. 70 Since then, evidence has accumulated supporting the notion that gap junction formation requires the presence of neighboring mechanical junctions, likely to provide stability for the docking and/or assembly of functional gap junction channels. Subsequent studies have demonstrated that loss of PKP2 expression leads to loss of immunoreactive Cx43 protein from the site of cell-cell apposition, as well as loss of gap junction-mediated coupling between cells. 71 Analogous studies have reached similar conclusions. 62, 72 Interactions between complexes can also be demonstrated between junctional and "nonjunctional" molecules at the intercalated disc. In particular, work of the Isom laboratory has shown that Na V 1.5 coprecipitates with Cx43 and with N-cadherin. 66, 73 More recent studies show that ankG, a component of the voltage-gated sodium channel, is also necessary for proper formation of cadherin junctions in epithelial cells. 74, 75 Furthermore, we demonstrated that Na V 1.5 and PKP2 coexist in the same molecular complex; we further showed that loss of PKP2 expression affects the amplitude and kinetics of the sodium current and the propagation velocity of action potentials in ventricular myocytes. 64 Overall, the emerging picture is that of the intercalated disc not as the summation of separate molecules with independent functions but rather, an "organelle" where macromolecular complexes interact to maintain synchrony within cell populations. It is within this organelle that the desmosome resides and where most ARVC-relevant mutations are found. It thus seems pertinent to consider the overall functional unit of the intercalated disc when seeking to understand the molecular pathology of ARVC.
The Intercalated Disc and ARVC
ARVC is an inherited arrhythmogenic disorder in which the primary mutation is not in a channel protein, or in a molecule that directly binds to a channel protein. Although alterations in cardiac structure are well-recognized arrhythmogenic substrates, patients with desmosomal mutations may present with severe arrhythmias in the absence of recognizable structural disease. The first link between desmosomal integrity and electric stability was provided by a landmark study showing loss of gap junction integrity in hearts of patients afflicted with Naxos disease. 42 Further studies exploring the molecular composition of the intercalated disc in hearts obtained from patients with Carvajal syndrome showed preservation of N-cadherin (and other proteins) at the sites of cell-cell apposition, whereas gap junction plaques were absent or drastically reduced. 43 These observations have been confirmed and expanded to include other intercalated disc proteins. In an elegant study, Asimaki et al showed that, independent of the causative mutation, the loss of immunodetectable plakoglobin at the intercalated disc is a consistent feature of the disease, and may serve as an important diagnostic tool for ARVC. 76 Taken together, these studies have provided the fundamental framework to suggest that, either directly or indirectly, a molecular crosstalk may occur within the domain of the intercalated disc whereby the loss of desmosomal integrity translates into disruption of the gap junction structure, with likely conse-quence to the electric stability of the heart. Additional experiments in animal and cellular models provide grounds for further speculation as to the molecular mechanisms underlying the clinical phenotype and mechanisms of arrhythmia in ARVC. Some of those studies are described below.
Desmosome-to-Nucleus Crosstalk and ARVC
The paragraphs above indicate that desmosomal molecules crosstalk with others expressed at the intercalated disc. Yet, the range of influence of desmosomal integrity may reach beyond the junctional membrane. Indeed, recent studies indicate that loss of desmoplakin expression associates with (1) increased abundance of nuclear plakoglobin, (2) a concurrent decrease in expression of c-Myc and Cyclin D1 (targeted genes of the Wnt/␤-catenin signaling), and (3) an increase in expression of adipogenic genes adiponectin and C/EBP-␣. 77 The authors have proposed a model whereby nuclear plakoglobin mediates suppression of the canonical Wnt pathway, leading to transdifferentiation of cardiomyocytes 77 or cardiac progenitor cells 78 into the adipocyte lineage. Yet, although data suggest that the origin of some adipocytes in desmosomal ARVC can be traced to cardiac progenitor cells, other sources cannot be discarded. Transcriptional regulation by desomosomal molecules, and, in particular, plakoglobin and PKPs, has emerged as an important area for future investigation.
Desmosomal Integrity and Junctional Complexes: Results From Cellular and Animal Models and Their Potential Relevance to the Molecular Pathology of ARVC
An in-depth characterization of the molecular mechanisms underlying the arrhythmic behavior in patients with ARVC is limited by the strict constraints inherent to human research. Animal models have served as important tools to advance our understanding of the pathophysiology of the disease. Purebred boxer dogs provide a well-characterized animal model. These animals present autosomal dominant disease with clinical manifestations strikingly similar to those described in humans, including a high incidence of ventricular fibrillation and sudden cardiac death. 79 Inherited ARVC in boxer dogs is associated with the loss of gap junctions, suggesting that, as in humans, disruption of the molecular composition of the intercalated disc is a component of the disease. 80 However, the genetic causes of ARVC in dogs remain unknown, and efforts to identify mutations in desmosomal molecules have been futile. Alternatively, a number of investigators have turned to genetically modified mice as a model to study ARVC pathophysiology.
Initial studies in murine lines demonstrated that germline deletion of either DSP or PKP2 leads to embryonic lethality. 81, 82 More recently, an animal model was generated in which deletion of desmoplakin was restricted to cardiac myocytes by crossing a floxed Dsp mouse with an ␣-myosin heavy chain-Cre recombinase transgenic mouse. 77 The cardiacrestricted deletion of the floxed alleles led to high lethality in desmoplakin-deficient embryos, although a higher survival rate was found in the heterozygous animals. Baseline resting electrocardiograms of those animals revealed a minor phenotype, although ventricular arrhythmias were inducible on single ventricular stimulation.
Animal models have also been used to characterize the consequence of overexpression of either wild-type or mutant desmosomal proteins. In particular, Yang et al analyzed 3 specific desmoplakin mutations for their effect in mice hearts: V30M, Q90R, and R2834H. 83 Expression was cardiacrestricted by means of the ␣-myosin heavy chain promoter. Overexpression of mutants V30M and Q90R led to embryonic lethality. On the other hand, overexpression of mutant R2834H associated with increased cardiomyocyte apoptosis, cardiac fibrosis and lipid accumulation, as well as ventricular enlargement and dysfunction. Yet, there was no myocyte replacement by adipose tissue, and the fibrous tissue replacement was restricted to focal areas. Interestingly, changes in the ultrastructure of the intercalated disc were noted, as well as interruption of the desmin-desmoplakin interaction. Of note, no effects on cardiac rhythm, and no increased prevalence of sudden death, were described in these animals.
Separate studies have characterized the effect of overexpression of a clinically identified mutation in the desmosomal cadherin protein desmoglein-2. 84 As in the case of desmoplakin, 83 overexpression of the wild-type gene did not yield a relevant phenotype. Transgenic mice with cardiac restricted expression of a desmoglein-2 gene containing mutation N271S recapitulated clinical features such as spontaneous ventricular arrhythmias and sudden death, cardiac dysfunction, biventricular dilatation and ventricular aneurysms. The phenotype was dependent on the level of expression of the transgene, with those animals expressing high levels of the N271S mutation being at a significantly higher risk of sudden death at a young age (30% death rate by 3.6 weeks of age). A detailed characterization of the electrophysiological properties of cardiac cells and tissue obtained from these animals remains to be carried out. Such studies could yield valuable information on the arrhythmogenic substrate responsible for arrhythmias not only in patients afflicted with this specific genotype but perhaps, for other patients diagnosed with ARVC.
It is important to emphasize that published studies of ARVC-relevant mutations in mice have relied on overexpression of a transgene above the background expression of the wild-type alleles, thus introducing a variable (excess gene dose) not present in patients with ARVC mutations. Studies using knock-in technology, in which the mutant sequence substitutes the wild-type allele, will allow for characterization of ARVC-relevant mutations under conditions in which expression levels better resemble those present in man. Finally, it is interesting to note that, although PKP2 is the gene most commonly associated with ARVC, genetically modified murine models of PKP2 mutations are not yet available. Future studies are likely to expand on the use of murine lines to help us understand the molecular mechanisms leading to ARVC in the human population.
ARVC-related arrhythmias commonly occur in the absence of major structural disease. On the other hand, patients with ARVC may present various degrees of fibrous and adipose tissue replacing the ventricular myocardium. Murine models have only partially recapitulated this myocyte loss with
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"fibrofatty infiltration," and the cellular/molecular origins of this aspect of the phenotype are incompletely understood. [81] [82] [83] [84] It is of interest to note that in all murine models of ARVC, transgenes have been cloned under the control of cardiac promoters; consequently, the role of noncardiac cells in the pathogenesis of the fibrofatty phenotype remains to be established. Murine models provide an opportunity to characterize, in the same animal population, the changes caused by one genetic modification on the morphology and function at various levels of organization, from the molecule to the living organism. However, generation of these models consumes resources and time, and only a few mutations can be assessed at one time. Moreover, the molecular/cellular phenotype may be affected secondarily to systemic changes resulting from the mutation, rather than as a direct consequence of molecular interactions occurring within the environment of the single cell. Cellular models thus provide a fundamental tool for understanding the molecular/cellular phenotype associated with ARVC. Interestingly, in studies where parallel investigations have been conducted in expression systems and in transgenic mice, the results between the 2 experimental models have been remarkably consistent. 77, 83 These data provide confidence on the applicability of cellular models and further suggest that the changes induced by desmosomal gene modification in the organism result, at least in part, from the changes in the biology of individual cells and/or their interactions with immediate neighbors. From that perspective, it is important that cellular models have confirmed the fundamental observation that disruption of the desmosome alters the integrity of the gap junction plaque, 71 as originally shown in human hearts afflicted with Naxos disease and with Carvajal syndrome 42, 43 and then in samples obtained from patients carrying mutations in other desmosomal genes. 76 Loss of PKP2 expression in cultured cardiac myocytes associates with loss of immunoreactive Cx43 from the site of cell-cell apposition, a decrease in Cx43 abundance, and an increased presence of Cx43 in the intracellular space. 71 Dye-coupling experiments revealed a Ϸ50% decrease in the extent of gap junction-mediated intercellular communication in cells where PKP2 was knocked down. A similar dependence of gap junction integrity on PKP2 expression has been observed in other cell systems. 72 These observations lend support to the hypothesis that gap junctions may be a component of the arrhythmogenic substrate. Yet, other ion channels could be involved as well. (In fact, studies in cellular and animal models suggest that a 50% decrease in Cx43 abundance does not modify, per se, the ability of an action potential to propagate between cells. 56, 57, [85] [86] [87] ) Indeed, biochemical analysis has demonstrated that PKP2 coimmunoprecipitates not only with Cx43 but also with the major ␣ subunit of the cardiac sodium channel, Nav1.5. 64 Voltage clamp experiments revealed that loss of PKP2 expression also leads to a decrease in amplitude and a shift in voltage-gating kinetics of the sodium current in adult cardiac myocytes. Optical mapping studies showed that PKP2 knockdown associates with a significant decrease in conduction velocity in cardiac cell monolayers and an increased propensity to reentrant arrhythmias, likely resulting from the combination of decreased electric coupling and impaired sodium current density. 64 Overall, these results suggest that desmosomes, gap junctions, and the voltage-gated sodium channel complex form a "functional triad" at the intercalated disc and that disruption of 1 desmosomal protein (PKP2) can affect 2 ion channel complexes, previously considered independent from each other, thus setting the stage for cardiac arrhythmias. Translation of these results to the condition of a heart expressing a PKP2 mutated allele, or mutations in other desmosomal proteins, awaits further studies.
Cellular Phenotype As a Tool in Risk Stratification of the Disease
In the field of channelopathies, a number of studies have addressed, in some cases successfully, a correlation between ion channel mutations and risk stratification. 88 Cellular expression models of mutant proteins have even allowed for assessment of the possible efficacy of drug therapy depending on the mutation present in a particular family. 88 However, in ARVC, application of cellular expression models as a tool to assess risk and potential therapy is complicated by the fact that this disorder is linked to mutations in a nonchannel protein. It is then crucial to identify target molecules that are primarily involved in electric synchrony and that are, on the other hand, functional partners of desmosomal molecules. It is also necessary to choose relevant cell systems in which the interaction between desmosomal proteins, and those relevant electrophysiological targets, can be studied. Recent studies point to gap junctions and, likely, the sodium channel complex as potential readouts of the effect of desmosomal mutations. Future studies should establish whether a valid genotype-cellular phenotype-clinical phenotype link can be established to aid in risk stratification of ARVC.
